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Carbon tetrachloride (CCl4) is a well-known hepatotoxicant, and its exposure induces hepatorenal injury via oxidative stress
and biochemical alterations. This study had been conducted to conﬁrm the protective role of propolis extract on CCl4-induced
hepatorenal oxidative stress and resultant injury. Propolis extracts collected from Gwalior district and 24 female Sprague Dawley
rats were used for experiment. Animals were exposed to CCl4 (0.15mL/kg, i.p.) for 12 weeks (5 days/week) followed by
treatment with propolis extract (200mg/kg, p.o.) for consecutive 2 weeks. CCl4 exposure signiﬁcantly depleted blood sugar and
hemoglobin level and raised the level of transaminases, alkaline phosphatase, lactate dehydrogenase, protein, urea, albumin,
bilirubin, creatinine, triglycerides, and cholesterol in serum. Lipid peroxidation was enhanced, whereas GSH was decreased
signiﬁcantly in liver and kidney in CCl4-intoxicated group. Ethanolic extract of propolis successfully prevented these alterations in
experimentalanimals.Activitiesofcatalase,adenosinetriphosphatase,glucose-6-phosphatase,acid,andalkalinephosphatasewere
also maintained towards normal with propolis therapy. Light microscopical studies showed considerable protection in liver and
kidney with propolis treatment, thus, substantiated biochemical observations. This study conﬁrmed hepatoprotective potential of
propolis extract against chronic injury induced by CCl4 by regulating antioxidative defense activities.
1.Introduction
The chronic liver diseases are common worldwide and
are characterized by a progressive evolution from steatosis
to chronic hepatitis, ﬁbrosis, cirrhosis, and hepatocellular
carcinoma [1, 2]. Free radicals and reactive oxygen species
(ROS) play a crucial role in development of liver diseases
[3]. The liver is exposed to absorbed drugs or xenobiotics in
concentrated form due to its unique vascular and metabolic
features. Drug-metabolizing enzymes detoxify many xeno-
biotics but bioactivate the toxicity of others [4]. In case
of bioactivation, liver is the ﬁrst organ exposed to the
damagingeﬀectsofnewlyformedtoxicsubstance.Therefore,
protective armaments for liver are of particular interest.
Considerable eﬀorts are being made to obtain useful herbal
medicines from documented medicinal plants [5]f o raw i d e
variety of clinical conditions. Dietary antioxidants of natural
products may serve as therapeutics to cope with liver damage
[3] against free radicals and ROS-induced liver diseases
pathology and progression. Natural antioxidants in complex
mixtures if ingested with the diet are more eﬃcacious
than pure compounds in preventing oxidative stress-related
pathologies due to particular interactions and synergisms
[3] by modulating antioxidant, drug-metabolizing, and
repairing enzymes along with acting as signaling molecules
in important cascades for cell survival [6, 7].
Propolis is an adhesive, resinous substance collected,
transformed and used by honeybees to seal holes in their
honeycombs, smooth out the internal walls, and protect
the entrance of intruders. Honeybees collect the resin
from cracks in the bark of trees and leaf buds. They
bring propolis back to the hive, where it is modiﬁed and
mixed with other substances, including bees’ own wax
and salivary secretions [8]. Propolis has been used in
folk medicine all over the world. It has anti-inﬂammatory,
immunoregulatory,bacteriostatic,andantibacterialactivities
[9–11]. It provides excellent cartilage protection suggesting
a potential application in joint disease [12]. Long-term
administration of propolis does not induce any signiﬁcant
change in seric parameters; thus, it might not have any
cardiac injury [13]. Propolis extracts present low toxicity to
experimental animals, with LD50 higher than 7g/kg for mice2 Evidence-Based Complementary and Alternative Medicine
[14, 15]. Previously we reported strong hepatoprotective
eﬀect of propolis against acute hepatic damage [16–21]
and subchronic hepatic injury induced by CCl4 [22]a n d
acetaminophen [23]. In the present communication, an
attempt has been made to explore potential of propolis in
preventing chronic hepatorenal injury.
2.MaterialandMethods
2.1. Animals and Hepatorenal Injury by CCl4. Female Spra-
gue Dawley rats (130 ± 10g) were kept (3/cage: 6/group)
in the animal house under standard husbandry condi-
tions (temp. 25 ± 2◦C; relative humidity 60 ± 5%; 12h
light/dark cycle). The animals were fed on pelleted diet
(Pranav Agro Industries Ltd., India) and drinking water ad
libitum. Experiments were conducted in accordance with the
guidelines set by the Institutional Animal Ethics Committee
(501/01/A/CPCSEA) of Jiwaji University. Hepatorenal injury
was induced by CCl4 (0.15mL/kg; diluted with liquid paraf-
ﬁn) that was administered for 12 weeks (5days/week) [24].
2.2. Preparation and Administration of Propolis. Crude prop-
olis from the hive of Apis mellifera was collected from
apiaries nearby Gwalior district (MP) by Professor O. P.
Agrawal, Senior Entomologist, School of Studies in Zoology,
Jiwaji University, Gwalior (India). Propolis is a plant-derived
product, and it has been proved that bees do not change its
chemical composition [25]. It is reported that more than 300
compoundsofdiﬀerentclassesarepresentinpropolisamong
which more than 100 are common worldwide. A lot of
knowledge has already been gathered on active components,
and one of the most important active principles was found
to be caﬀeic acid phenethyl ester [26]. A 90% ethanolic
extract was obtained as described previously [16, 17], yield
of dried residue was about 61.4% (w/w) and kept at 4◦Cf o r
further use. Aqueous suspension of propolis was prepared in
1% gum acacia suspension, and selected optimum dose was
administered (200mg/kg, p.o.) to the animals for 2 weeks on
thebasisofourpreviousstudies[22,23].Silymarinwasgiven
as positive control in respect to propolis.
2.3. Experimental Design. Animals of group 1 received
vehicle only and served as normal control. Animals of group
2–4 received CCl4 for 12 weeks (5days/week) and group
2 served as experimental control. Group 3 and 4 received
treatments of propolis and silymarin, respectively, for 2
weeks (5days/week). Blood was collected from retro-orbital
venous plexus after 48h of the last administration. The
animals of entire groups were euthanized; liver and kidney
were immediately excised and processed for biochemical
analyses and histological preparations. Scheme of diﬀerent
treatments is given in Table 1.
2.4. Isolation of Serum and Homogenate Preparation. Serum
was isolated after keeping the blood for 1h at room
temperature followed by centrifugation at 1000g for 15min
and stored at −20◦C until analyzed. Tissue samples of liver
and kidney were homogenized with ice-cold 150mM KCl
for the determination of TBARS and CAT activity and in
1% sucrose for GSH determination. Homogenates of liver
and kidney were prepared in chilled hypotonic solution
(10%w/v) for other biochemical assays, that is, total protein,
cholesterol, adenosine triphosphatase (ATPase), acid, and
alkaline phosphatase (ACPase and ALPase).
2.5. Determination of Hepatorenal Marker Enzymes in Serum
and Other Blood Biochemical Endpoints. Blood was imme-
diately used for determination of hemoglobin [27]a n d
blood sugar level [28]. Serum was used for the determi-
nation of aspartate aminotransferase (AST) [29], alanine
aminotransferase (ALT) [29], alkaline phosphatase (SALP)
[30], lactate dehydrogenase (LDH) [31], and serum protein
contents [32]. Serum bilirubin, albumin, urea, creatinine,
andtriglyceridesweredeterminedbyE-Merck’skitaccording
to the manufacturer’s instructions.
2.6. Assessment of Peroxidative Stress and Antioxidant Status.
Lipidperoxidation(LPO)wasmeasuredusingthiobarbituric
acid (TBA) [33] and expressed as n moles TBARS/g tissue
using an extinction coeﬃcient of 1.56 × 105/M/cm. The
GSH measurement was performed using dithionitrobenzoic
acid [34]. The GSH level was calculated using an extinction
coeﬃcient of 13600/M/cm and expressed as μ moles GSH/g
tissue. Catalase activity was determined as per method
of Aebi [35]. Decomposition of H2O2 was monitored by
decrease in the absorbance at λ 240nm. H2O2 concentration
was calculated using extinction coeﬃcient of 0.0394/mM/cm
and activity was expressed as n moles H2O2/min/mg protein.
2.7. Tissue Biochemical Assay. Fresh tissues of liver and kid-
ney were immediately processed to determine glycogen by
anthrone reagent method [36]. Total proteins were deter-
mined using bovine serum albumin as standard, and blue
color was developed by the reaction of proteins and Folin-
Ciocalteau reagent [32]. Hepatic and renal triglycerides were
determined according to Neri and Frings [37]. Determina-
tion of enzymatic activities including ACPase [30], ALPase
[30],andATPase[38]wasalsoperformedinliverandkidney.
2.8. Histopathological Observations. For histological studies,
samples from liver and kidney were ﬁxed in Bouin’s ﬁxative
and processed routinely for embedding in paraﬃn. Tissue
sections of 5μm thickness were stained with hematoxylin
and eosin (H&E) and examined under compound light
microscope.
2.9.Statistics. Dataareexpressedasmean ±SEofsixanimals
used in each group. Statistical analysis was carried out by one
way analysis of variance (ANOVA) considered signiﬁcant at
P ≤ 0.05 followed by Student’s t-test [39].
3. Results
3.1. Hepatorenal Marker Enzymes in Serum and Other Blood
Biochemical Endpoints. Chronic exposure to CCl4 exhibited
elevation in the leakage of AST, ALT, LDH, and SALPEvidence-Based Complementary and Alternative Medicine 3
Table 1: Scheme for diﬀerent treatments and durations.
Treatments 1st–12th weeks 13th-14th weeks Last day of 14th week
Gr 1: normal control Liquid paraﬃn Gum acacia suspension Euthanized
Gr 2: experimental control CCl4 (0.15mL/kg) Gum acacia suspension Euthanized
Gr 3: propolis treatment CCl4 (0.15mL/kg) Propolis (200mg/kg) Euthanized
Gr 4: silymarin treatment CCl4 (0.15mL/kg) Silymarin (50mg/kg) Euthanized
signiﬁcantly (P ≤ 0.05) (Figure 1). Treatment of propolis
extract signiﬁcantly reduced the leakage of AST, ALT, LDH,
and SALP in circulation (P ≤ 0.05), thereby, conﬁrming its
protective eﬀect in chronic injury. Chronic administration
of CCl4 decreased hemoglobin level, whereas signiﬁcant rise
was observed in blood sugar, serum triglycerides and choles-
terol (P ≤ 0.05) (Figure 2). Propolis therapy signiﬁcantly
reversed the level of hemoglobin and blood sugar as well
as serum triglycerides and cholesterol towards control (P ≤
0.05). CCl4 exposure signiﬁcantly increased serum albumin,
bilirubin, urea, and creatinine (P ≤ 0.05) (Figure 3).
Treatment with propolis for 2 weeks signiﬁcantly decreased
the level of these serological variables and brought the values
very near to control group (P ≤ 0.05). Eﬃcacy of propolis
was well compared with positive control silymarin, and per-
centprotection clearlyshowed that propolis possesses almost
equal degree of protection in all biochemical endpoints as
silymarin-treated positive control.
3.2. Peroxidative Stress and Antioxidant Status. Peroxidative
stress and antioxidant status both in liver and kidney tissues
weredeterminedintermsofLPO,GSH,andcatalase(Figures
4(a)–4(f)). CCl4 administration enhanced the formation of
TBARS in hepatic and renal tissues after its chronic exposure
(P ≤ 0.05). Therapy with propolis extract diminished the
production of TBARS (P ≤ 0.05), which ultimately reduced
peroxidative stress up-to a considerable extent. The level of
GSH and catalase was signiﬁcantly decreased in liver and
kidney after administration of CCl4 (P ≤ 0.05). Propolis
extract was therapeutically eﬀective in restoring GSH level
and in maintaining CAT enzyme in liver and kidney in
a signiﬁcant manner (P ≤ 0.05), which could help in
mitigating oxidative stress.
3.3. Tissue Biochemical Assay. Signiﬁcantly enhanced enzy-
matic activity of ACPase was found in liver and kidney after
CCl4 exposure (P ≤ 0.05; Table 2). Propolis therapy was
signiﬁcantly eﬀective in reducing elevated activity of ACPase
in both tissues (P ≤ 0.05). Signiﬁcant fall was noticed in
activities of ALPase and ATPase in liver and kidney after 12-
week administration of CCl4 (Table 2; P ≤ 0.05). Therapeu-
tic eﬀect of propolis extract was found to be signiﬁcant in
both organs, and altered enzymatic activities were reversed
towards control (P ≤ 0.05). Signiﬁcant fall in total protein
and glycogen contents was observed after chronic exposure
to CCl4, whereas triglycerides were increased signiﬁcantly in
liver and kidney (P ≤ 0.05; Table 3). Therapy with propolis
extract alleviated total protein and glycogen contents and
regulated hepatic triglycerides towards control (P ≤ 0.05).
Propolis was found to be equally eﬀective as ilymarin on the
basis of percent protection.
3.4. Histopathological Observations. Liver of control rats
depicted regular histoarchitecture (Figure 5(a)). Liver sec-
tions of chronic CCl4 toxicity showed degeneration so liver
cells were seen swollen. It is encountered simultaneously
with ballooning degeneration and steatosis. Focal necrosis
was seen clearly. Nuclear changes such as karyopyknosis and
degeneration of the cell membrane indicated necrosis. These
liver showed presence of ﬁbrous septa with heterogenous
population of nonparenchymal cells, foamy degeneration
due to plenty of vacuolation and disturbed hepatic cord
array (Figures 5(b), 5(c),a n d5(d)). The protective eﬀect
of propolis against CCl4-induced chronic liver damage
and cirrhosis was conﬁrmed by conventional histological
examinations. Liver sections obtained from animals, those
followed by propolis therapy, showed consistent reduction
of liver necrosis and inﬂammation. Moreover, the cirrhosis
process was seen reduced. Proper sinusoidal spaces and cord
arrangement were clearly visible with binuclear hepatocytes
indicating regenerative eﬀects (Figure 5(e)). Silymarin treat-
ment also improved histoarchitecture showing well-formed
hepatic cord arrangements with clearly visible nuclei and
sinusoidal spaces (Figure 5(f)).
Kidneyofcontrolratshowedregularhistologicalfeatures
(Figure 6(a)). Administration of CCl4 for 12 weeks provoked
histopathological lesions, including disruption in the epithe-
lialcellsofthetubules;proximaltubulesshowedhypertrophy
in proximal tubules with debris in the lumen due to which
the lumen was found to be obstructed. The glomeruli occu-
pied whole Bowman’s capsule, medullary tubules showed
degeneration, and nuclei showed apical position (Figures
6(b) and 6(c)). Propolis therapy made proximal tubules well
organized (Figure 6(d)), glomeruli reversed to the regular
shape leaving wider space between glomerulus and Bow-
man’scapsulewall(Figure 6(e)).Administrationofsilymarin
improved histological features of kidney. Endothelial lining
was improved, and cortical and medullary tubules were
f o u n dt ob ew e l lf o r m e d( Figure 6(f)).
4. Discussion
Various environmental toxicants and clinically useful drugs
cancauseseverecellulardamagesindiﬀerent organsthrough
their metabolic activation. CCl4 is one of such extensively
studied toxicants that has been used to induce liver injury for


























































Figure 1: Showing therapeutic potential of propolis on CCl4-induced alteration in liver marker enzymes of serum. Values are mean ± SE
of n = 6 in each group. @Signiﬁcant for ANOVA at 5% level. P value CCl4 versus normal at # ≤ 0.05; P value treatment versus CCl4
at ∗≤0.05 for Student’s t-test; F variance for ANOVA of AST = 60.3†,A L T= 145†,L D H= 114†,S A L P= 204†. Abbreviations: Control
(C); Carbon tetrachloride (CCl4); Propolis (P); Silymarin (S); Aspartate aminotransferase (AST); Alanine aminotransferase (ALT); Lactate
dehydrogenase (LDH), and Alkaline phosphatase (SALP).
The reactive metabolite trichloromethyl radicals (•CCl3)
are formed from the metabolic conversion of CCl4 by
cytochrome P-450 [41]. As O2 tension rises, greater fraction
of •CCl3 present in the system reacts rapidly with O2,a n d
many orders of magnitude of more reactive free radicals
CCl3OO• are generated [42]. These free radicals initiate
peroxidation of membrane polyunsaturated fatty acids [43]
and covalently bind to microsomal lipids and proteins [44]
resulting in ROS. Various enzymatic and nonenzymatic
systems have been developed by the cell to cope with ROS
and other free radicals. However, a condition of oxidative






































































Figure 2: Showing therapeutic potential of propolis on CCl4-induced alteration in serological parameters. Values are mean ± SE of n = 6
in each group. @Signiﬁcant for ANOVA at 5% level. P value CCl4 versus normal at # ≤ 0.05; P value treatment versus CCl4 at ∗≤0.05
for Student’s t-test; F variance for ANOVA of hemoglobin = 4.44†, blood sugar = 6.57†,t r i g l y c e r i d e s= 46.9†, and cholesterol = 7.81†.
Abbreviations: Control (C); Carbon tetrachloride (CCl4); Propolis (P); Silymarin (S).
ROS [45]. The ROS also aﬀect antioxidant defense mech-
anisms, reduce intracellular concentration of GSH, decrease
the activity of CAT, and cause organ injury and carcino-
genesis [46].
Lipid peroxidations as well as altered levels of some
endogenous scavengers are taken as reliable indices for
oxidative stress [47, 48]. In the present study, administration
of CCl4 enhanced LPO in liver and kidney. Treatment of
propolis extract inhibited the generation of TBARS in both
tissues that conﬁrmed its antilipid peroxidative eﬀects in
chronic condition of hepatorenal injury. GSH constitutes the
ﬁrstlineofdefenseagainstfreeradicals[18].Anotherdefense
mechanism involves antioxidant enzymes, including CAT
that converts active oxygen molecules into nontoxic com-
pounds. CCl4 administration decreased the activity of CAT












































Figure 3: Showing therapeutic potential of propolis on CCl4-induced alteration in speciﬁc serum markers. Values are mean ± SE of n = 6
in each group. @Signiﬁcant for ANOVA at 5% level. P value CCl4 versus normal at # ≤ 0.05; P value treatment versus CCl4 at ∗≤0.05 for
Student’s t-test; F variance for ANOVA of albumin = 7.34†, bilirubin = 39.0†,u r e a= 64.1†, and creatinine = 56.1†. Abbreviations: Control
(C); Carbon tetrachloride (CCl4); Propolis (P); Silymarin (S).
agreement with earlier reports [19, 20]. Oral administration
of propolis reactivated the activities of CAT and restored
GSH level, which in turn increased the detoxiﬁcation of
active metabolites of CCl4. Flavonoids and their esters in
propolis are pharmacologically active molecules and have
been hypothesized to inﬂuence the antioxidant activity of
propolis [49, 50]. AST, ALT, SALP, and LDH are sensitive
markers of liver injury, and several fold increase in the
release of these enzymes indicated severity of damage in
chronic study. Serum bilirubin, albumin, urea, creatinine,
and triglycerides were also found to be abnormally higher,
which indicated hepatic and renal damage. Administration
of propolis extract brought these endpoints towards control









































































































































































































Figure 4: Showing therapeutic potential of propolis on CCl4-induced hepatorenal oxidative stress. Values are mean ± SE of n = 6i ne a c h
group. @Signiﬁcant for ANOVA at 5% level. P value CCl4 versus normal at # ≤ 0.05; P value treatment versus CCl4 at ∗≤0.05 for Student’s
t-test; F variance for ANOVA of hepatic LPO = 104†, renal LPO = 45.2†, hepatic GSH = 50.3†, renal GSH = 27.7†, hepatic CAT = 37.7†,a n d






















Figure 5: (a) Photomicrograph of control liver with polygonal hepatocytes cordially arranged around hepatic central vein. Hepatic nuclei
(N), uniform sinusoidal spaces (S) terminating into central vein (CV) were clearly visible (200x). (b) Liver sections of CCl4 induced chronic
hepatic injury with disturbed cord arrangement of hepatocytes, vacuolation (V) due to collapsed cellular membranes, high accumulation
of nonparenchymal or inﬂammatory cells (NP) and irregular sinusoids (200x). (c and d) Liver sections of CCl4 induced chronic hepatic
injury with disturbed cord arrangement of hepatocytes and high degree of vacuolation (V) due to collapsed cellular membranes (400x). (e)
Photomicrographof liver afterpropolistherapywith minimaldegree of vacuolation, better formedpolygonal hepatocytes cordiallyarranged
towards hepatic central vein (CV). Hepatic nuclei (N), uniform sinusoids (S) terminating into central vein were clearly visible (200x). (f)
















Figure 6: (a) Photomicrograph of kidney of control rat showing well-formed Bowman’s capsule and normal glomeruli (G), uniform
space between glomerulus and capsule wall, tubular lumen with basal and apical nuclei (200x). (b) CCl4 administration caused swelling
in glomerulus and tubular obstruction. loss of glomerulus space (thick arrows) and (200x). (c) CCl4 exposure caused swelling in glomerulus
so that space between glomerulus and capsule wall (curved arrow) was reduced (400x). (d): Administration of propolis retained the kidney
histoarchitecture with opened lumen of tubules (T) and uniform space between glomerulus and capsule wall (curved arrow) (200x). (e)
Propolis therapy maintained uniform space between glomerulus and capsule wall (curved arrow) (400x). (f) Silymarin therapy recovered
the kidney histoarchitecture with wider lumen of tubules (T) (400x).10 Evidence-Based Complementary and Alternative Medicine
Table 2: Potential of propolis in maintaining metabolizing enzymes. (Values are mean ± SE from six rats in each group.)
Groups
Adenosine triphosphatase Acid phosphatase Alkaline phosphatase
(mgPi/100mg/min) (mgPi/100mg/h) (mgPi/100mg/h)
Hepatic Renal Hepatic Renal Hepatic Renal
Control 2020 ± 111 2500 ± 138 250 ± 30.9 270 ± 14.9 74.0 ± 4.09 2580 ± 142
CCl4 987 ± 54.5# 1095 ± 60.5# 1395 ± 77.1# 1440 ± 79.6# 36.0 ± 1.99# 716 ± 39.6#
CCl4 + Propolis 1742 ± 96.2∗ 1775 ± 98.1∗ 338 ± 18.7∗ 378 ± 20.9∗ 68.0 ± 3.75∗ 1591 ± 87.9∗
% Protection 73.1% 48.4% 92.3% 90.7% 84.2% 46.9%
CCl4 + Silymarin 1806 ± 99.8∗ 1880 ± 232∗ 335 ± 18.5∗ 342 ± 18.9∗ 69.0 ± 3.81∗ 1665 ± 92.1∗
% Protection 79.3% 55.8% 92.6% 93.8% 86.8% 50.9%
F Variance 28.1† 36.7† 208† 202† 29.3† 73.1†
P value CCl4 versus control at # ≤ 0.05; therapy versus CCl4 at ∗≤0.05; †signiﬁcant for analysis of variance P ≤ 0.05.
Table 3: Eﬀect of propolis on hepatorenal biochemical assay against carbon tetrachloride intoxication. (Values are mean ± SE from six rats
in each group.)
Groups
Total protein contents Glycogen contents Triglycerides
(mg/100mg) (mg/100g) (mg/100mg)
Hepatic Renal Hepatic Renal Hepatic Renal
Control 15.7 ± 0.86 15.1 ± 0.83 2700 ± 149 84.0 ± 4.64 3.20 ± 0.17 2.95 ± 0.16
CCl4 12.3 ± 0.67# 13.1 ± 0.72# 984 ± 54.3# 51.1 ± 2.81# 8.30 ± 0.45# 6.78 ± 0.37#
CCl4 + Propolis 15.3 ± 0.84∗ 14.1 ± 0.77∗ 2128 ± 117∗ 79.0 ± 4.36∗ 3.80 ± 0.21∗ 3.37 ± 0.18∗
% Protection 88.2% 50.0% 66.6% 84.8% 88.2% 89.1%
CCl4 + Silymarin 15.4 ± 0.85∗ 14.3 ± 0.79∗ 2240 ± 123∗ 81.0 ± 4.47∗ 3.60 ± 0.19∗ 3.58 ± 0.19∗
% Protection 91.1% 60.0% 73.1% 90.9% 92.2% 83.5%
F Variance 4.58† 1.32 46.9† 163† 84.6† 61.6†
P value CCl4 versus control at # ≤ 0.05; therapy versus CCl4 at ∗≤0.05; †signiﬁcant for analysis of variance P ≤ 0.05.
the parameters, eﬃcacy of propolis was found to be the
same as sylimarin treatment. Evidently, histopathological
examinations of liver and kidney also supported propolis
therapy as it helped in improving cellular architecture. This
clearly indicated membrane stabilizing eﬀect of propolis
probably by scavenging free radicals.
GSH depletion increases the sensitivity of cells to various
aggressions and also has several metabolic eﬀects, for exam-
ple, a decrease in the rate of gluconeogenesis or an increase
in glycogenolysis [51]. Fall in protein and glycogen contents
in liver and kidney tissues was observed in this investigation
that might be associated with increased hepatorenal injury,
which in turn resulted into decreased capacity of syn-
thesize protein and glycogen. Propolis therapy augmented
protein and glycogen contents in liver and kidney, which
indicated that propolis prevented hepatorenal injury and
improved physiology of these organs by modulating cellular
metabolism and regeneration.
Activities of membranes enzymes ATPase and ALPase
were decreased considerably in liver and kidney after CCl4
exposure [19, 23, 24]. Free radicals are produced inside
mitochondria and are frequently released into the cytosol.
The production of ATP in the mitochondria involves
the transport of protons across the inner mitochondrial
membrane via the electron transport chain. Uncoupling of
oxidative phosphorylation leads to fall in activity of ATPase.
The use of ATPase level measurement was considered as an
appropriateindexofmembranedamage.Signiﬁcantrecovery
was found in these enzymes with the treatment of propolis.
It may be suggested that impaired mitochondrial oxidative
phosphorylation in liver is retained thereby preventing
depletion of ATP energy stores [5]. Considerable reversal in
ATPase, ALPase, and ACPase activities indicated membrane
stabilizingeﬀectofpropolisextract.Propolisisalsosupposed
to be helpful in absorption and utilization of various miner-
als due to the presence of organic acid derivatives in it, which
in turn improved physiological functions by regulating the
ion dependent enzymatic activities [52]. Eﬃcacy of propolis
was found to be the same as of silymarin on the basis of
percent protection.
Since, liver and kidneys are closely related organs, which
take part in diﬀerent metabolic and excretion events. Any
abnormality in liver may also lead to impairment in kidney
functions. That is why both the organs had been taken into
consideration in this study. In conclusion, results of this
study validate the folklore use of propolis against various
ailments. Propolis is interestingly eﬀective in ameliorating
acute, subchronic, and chronic injury to liver. It also has
wider therapeutic index, and thus it may serve as clinically
useful hepatoprotective natural product in future.
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